Marshall Wace North America’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$9.48M	Sell	214,034 -77,955	-27%	-$3.57M	0.04%	367
2021 Q2	$16.6M	Sell	291,989 -169,712	-37%	-$12M	0.07%	289
2021 Q1	$34.6M	Sell	461,701 -259,407	-36%	-$21.3M	0.14%	170
2020 Q4	$62.4M	Buy	721,108 +299,169	+71%	+$22.1M	0.28%	90
2020 Q3	$25.8M	Buy	+421,939	New	+$21.4M	0.17%	156
2020 Q2	–	Sell	-9,482	Closed	-$272K	–	1438
2020 Q1	$272K	Buy	+9,482	New	+$549K	﹤0.01%	862
2019 Q4	–	Sell	-167,060	Closed	-$23.4M	–	1555
2019 Q3	$23.4M	Buy	167,060 +40,843	+32%	+$6.83M	0.13%	158
2019 Q2	$23.1M	Sell	126,217 -414,191	-77%	-$70.7M	0.14%	139
2019 Q1	$86M	Buy	540,408 +53,704	+11%	+$7.78M	0.61%	44
2018 Q4	$46.6M	Sell	486,704 -2,444	-0.5%	-$280K	0.45%	64
2018 Q3	$69.1M	Sell	489,148 -38,468	-7%	-$5.94M	0.47%	57
2018 Q2	$82.6M	Sell	527,616 -104,484	-17%	-$16.4M	0.47%	46
2018 Q1	$102M	Sell	632,100 -4,917	-0.8%	-$835K	0.51%	40
2017 Q4	$105M	Buy	637,017 +580,056	+1,018%	+$56.2M	0.58%	32
2017 Q3	$3.53M	Sell	56,961 -285,277	-83%	-$22.4M	0.02%	646
2017 Q2	$27.4M	Sell	342,238 -157,667	-32%	-$11.4M	0.2%	131
2017 Q1	$35.5M	Buy	+499,905	New	+$29.3M	0.28%	102